Recurrent neural network for predicting absence of heterozygosity from low pass WGS with ultra-low depth.

Journal: BMC genomics
PMID:

Abstract

BACKGROUND: The absence of heterozygosity (AOH) is a kind of genomic change characterized by a long contiguous region of homozygous alleles in a chromosome, which may cause human genetic disorders. However, no method of low-pass whole genome sequencing (LP-WGS) has been reported for the detection of AOH in a low-pass setting of less than onefold. We developed a method, termed CNVseq-AOH, for predicting the absence of heterozygosity using LP-WGS with ultra-low sequencing data, which overcomes the sparse nature of typical LP-WGS data by combing population-based haplotype information, adjustable sliding windows, and recurrent neural network (RNN). We tested the feasibility of CNVseq-AOH for the detection of AOH in 409 cases (11 AOH regions for model training and 863 AOH regions for validation) from the 1000 Genomes Project (1KGP). AOH detection using CNVseq-AOH was also performed on 6 clinical cases with previously ascertained AOHs by whole exome sequencing (WES).

Authors

  • Fei Tang
    Division of Biostatistics, University of Miami.
  • Zhonghua Wang
    Shandong Sport University, Jinan 250102, Shandong, China.
  • Yan Sun
    Department of Biochemistry, Albert Einstein College of Medicine, New York, NY, United States.
  • Linlin Fan
    Clin Lab, BGI Genomics, Tianjin, 300308, China.
  • Yun Yang
    Department of Chemistry, South University of Science and Technology, Shenzhen 518055, China.
  • Xueqin Guo
    Clin Lab, BGI Genomics, Wuhan, 430074, China.
  • Yaoshen Wang
    Clin Lab, BGI Genomics, Tianjin, 300308, China.
  • Saiying Yan
    Clin Lab, BGI Genomics, Tianjin, 300308, China.
  • Zhihong Qiao
    Clin Lab, BGI Genomics, Tianjin, 300308, China.
  • Yun Li
    School of Public Health, University of Michigan, Ann Arbor, MI, USA.
  • Ting Jiang
    School of Information and Communication Engineering, Beijing University of Posts and Telecommunications, Beijing 100876, China.
  • Xiaoli Wang
    Demonstration Center of Future Product, Beijing Aircraft Technology Research Institute, COMAC, Beijing, China.
  • Jianfen Man
    Clin Lab, BGI Genomics, Wuhan, 430074, China.
  • Lina Wang
    Department of Biochemistry and Molecular Biology, Shandong University School of MedicineJinan, P. R. China; Central Laboratory, The Second Hospital of Shandong UniversityJinan, P. R. China.
  • Shunyao Wang
    BGI Genomics, Shenzhen, 518083, China.
  • Huanhuan Peng
    Clin Lab, BGI Genomics, Shenzhen, 518083, China.
  • Zhiyu Peng
    Department of Ophthalmology, Fudan Eye & ENT Hospital, Shanghai, China.
  • Xiaoyuan Xie
    Tianjin Women's and Children's Health Center, Tianjin, 300070, China. xiexiaoyuan2001@163.com.
  • Lijie Song
    Clin Lab, BGI Genomics, Tianjin, 300308, China. songlijie@bgi.com.